While these emerging studies provide promising results, they note that GLP-1 RAs are more effective in, preserving periodontal and peri-implant health in T2DM patients than in directly treating periodontitis or peri-implantitis ( Ahmad et al
Davis was frustrated that he now had to work with Vida, but he did as he was told: He got new blood work, filled out health questionnaires and did video visits with a nurse
Trials of Safety and Efficacy There is now extensive research concerning the efficacy and general safety of the first four DPP-4 inhibitors: sitagliptin, linagliptin, vildagliptin and saxagliptin
Analytic Approach National all-payer claims data were used to examine patient volumes for bariatric weight loss surgery, cardiac catheterization, GLP-1 medication use and SGLT2 inhibitor medication use from 2018 to 2023
Synbiotics and probiotics in the critically ill after the PROPATRIA trial